View of Bortezomib Plus Dexamethasone as the Induction Therapy in Newly Diagnosed Multiple Myeloma Patients: A Phase II Study in Thai Patients

Return to Article Details Bortezomib Plus Dexamethasone as the Induction Therapy in Newly Diagnosed Multiple Myeloma Patients: A Phase II Study in Thai Patients Download Download PDF